Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP)

The activation of the endocannabinoid system controls the release of many neurotransmitters involved in the brain reward pathways, including glutamate. Both endocannabinoid and glutamate systems are crucial for alcohol relapse. In the present study, we hypothesize that N-methyl-D-aspartate (NMDA) gl...

Full description

Bibliographic Details
Main Authors: Marta Marszalek-Grabska, Irena Smaga, Paulina Surowka, Pawel Grochecki, Tymoteusz Slowik, Malgorzata Filip, Jolanta H. Kotlinska
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/15/7940
id doaj-d3e6b69348b841cdb807d3ae248b1fca
record_format Article
spelling doaj-d3e6b69348b841cdb807d3ae248b1fca2021-08-06T15:24:49ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-07-01227940794010.3390/ijms22157940Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP)Marta Marszalek-Grabska0Irena Smaga1Paulina Surowka2Pawel Grochecki3Tymoteusz Slowik4Malgorzata Filip5Jolanta H. Kotlinska6Department of Experimental and Clinical Pharmacology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Drug Addiction Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, PolandAffective Cognitive Neuroscience Laboratory, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, PolandDepartment of Pharmacology and Pharmacodynamics, Medical University of Lublin, 20-093 Lublin, PolandExperimental Medicine Center, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Drug Addiction Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, PolandDepartment of Pharmacology and Pharmacodynamics, Medical University of Lublin, 20-093 Lublin, PolandThe activation of the endocannabinoid system controls the release of many neurotransmitters involved in the brain reward pathways, including glutamate. Both endocannabinoid and glutamate systems are crucial for alcohol relapse. In the present study, we hypothesize that N-methyl-D-aspartate (NMDA) glutamate receptors regulate the ability of a priming dose of WIN 55,212-2 to cross-reinstate ethanol-induced conditioned place preference (CPP). To test this hypothesis, ethanol-induced (1.0 g/kg, 10% <i>w</i>/<i>v</i>, i.p.) CPP (unbiased method) was established using male adult Wistar rats. After CPP extinction, one group of animals received WIN 55,212-2 (1.0 and 2.0 mg/kg, i.p.), the cannabinoid receptor 1 (CB1) agonist, or ethanol, and the other group received memantine (3.0 or 10 mg/kg, i.p.), the NMDA antagonist and WIN 55,212-2 on the reinstatement day. Our results showed that a priming injection of WIN 55,212-2 (2.0 mg/kg, i.p.) reinstated (cross-reinstated) ethanol-induced CPP with similar efficacy to ethanol. Memantine (3.0 or 10 mg/kg, i.p.) pretreatment blocked this WIN 55,212-2 effect. Furthermore, our experiments indicated that ethanol withdrawal (7 days withdrawal after 10 days ethanol administration) down-regulated the CNR1 (encoding CB1), GRIN1/2A (encoding GluN1 and GluN2A subunit of the NMDA receptor) genes expression in the prefrontal cortex and dorsal striatum, but up-regulated these in the hippocampus, confirming the involvement of these receptors in ethanol rewarding effects. Thus, our results show that the endocannabinoid system is involved in the motivational properties of ethanol, and glutamate may control cannabinoid induced relapse into ethanol seeking behavior.https://www.mdpi.com/1422-0067/22/15/7940cannabinoidglutamateCNR1GRIN1GRIN2Aethanol relapse
collection DOAJ
language English
format Article
sources DOAJ
author Marta Marszalek-Grabska
Irena Smaga
Paulina Surowka
Pawel Grochecki
Tymoteusz Slowik
Malgorzata Filip
Jolanta H. Kotlinska
spellingShingle Marta Marszalek-Grabska
Irena Smaga
Paulina Surowka
Pawel Grochecki
Tymoteusz Slowik
Malgorzata Filip
Jolanta H. Kotlinska
Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP)
International Journal of Molecular Sciences
cannabinoid
glutamate
CNR1
GRIN1
GRIN2A
ethanol relapse
author_facet Marta Marszalek-Grabska
Irena Smaga
Paulina Surowka
Pawel Grochecki
Tymoteusz Slowik
Malgorzata Filip
Jolanta H. Kotlinska
author_sort Marta Marszalek-Grabska
title Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP)
title_short Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP)
title_full Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP)
title_fullStr Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP)
title_full_unstemmed Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP)
title_sort memantine prevents the win 55,212-2 evoked cross-priming of ethanol-induced conditioned place preference (cpp)
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-07-01
description The activation of the endocannabinoid system controls the release of many neurotransmitters involved in the brain reward pathways, including glutamate. Both endocannabinoid and glutamate systems are crucial for alcohol relapse. In the present study, we hypothesize that N-methyl-D-aspartate (NMDA) glutamate receptors regulate the ability of a priming dose of WIN 55,212-2 to cross-reinstate ethanol-induced conditioned place preference (CPP). To test this hypothesis, ethanol-induced (1.0 g/kg, 10% <i>w</i>/<i>v</i>, i.p.) CPP (unbiased method) was established using male adult Wistar rats. After CPP extinction, one group of animals received WIN 55,212-2 (1.0 and 2.0 mg/kg, i.p.), the cannabinoid receptor 1 (CB1) agonist, or ethanol, and the other group received memantine (3.0 or 10 mg/kg, i.p.), the NMDA antagonist and WIN 55,212-2 on the reinstatement day. Our results showed that a priming injection of WIN 55,212-2 (2.0 mg/kg, i.p.) reinstated (cross-reinstated) ethanol-induced CPP with similar efficacy to ethanol. Memantine (3.0 or 10 mg/kg, i.p.) pretreatment blocked this WIN 55,212-2 effect. Furthermore, our experiments indicated that ethanol withdrawal (7 days withdrawal after 10 days ethanol administration) down-regulated the CNR1 (encoding CB1), GRIN1/2A (encoding GluN1 and GluN2A subunit of the NMDA receptor) genes expression in the prefrontal cortex and dorsal striatum, but up-regulated these in the hippocampus, confirming the involvement of these receptors in ethanol rewarding effects. Thus, our results show that the endocannabinoid system is involved in the motivational properties of ethanol, and glutamate may control cannabinoid induced relapse into ethanol seeking behavior.
topic cannabinoid
glutamate
CNR1
GRIN1
GRIN2A
ethanol relapse
url https://www.mdpi.com/1422-0067/22/15/7940
work_keys_str_mv AT martamarszalekgrabska memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp
AT irenasmaga memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp
AT paulinasurowka memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp
AT pawelgrochecki memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp
AT tymoteuszslowik memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp
AT malgorzatafilip memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp
AT jolantahkotlinska memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp
_version_ 1721218430594449408